Latest Derivatives News

Page 4 of 44
TPC Consolidated Limited reported a 4.1% revenue increase to $103.6 million and a 62% jump in underlying EBITDA for the half-year ended December 2025, while the proposed acquisition scheme faces regulatory hurdles.
Maxwell Dee
Maxwell Dee
25 Feb 2026
Imricor Medical Systems saw a sharp 69.5% decline in revenue for 2025, driven by clinical trial impacts, yet narrowed its net loss to $25.3 million as it secured FDA clearance for key products post-year-end.
Ada Torres
Ada Torres
25 Feb 2026
Tetratherix Limited reported a $4.6 million statutory loss for the first half of FY26, driven by increased R&D and manufacturing investments, while making significant progress in clinical trials and securing key global partnerships.
Ada Torres
Ada Torres
24 Feb 2026
Orthocell Limited has reported a record half-year revenue of $6.2 million, driven by accelerating sales of its regenerative medicine products and expanding global footprint. The company’s US commercial launch of Remplir™ is gaining momentum alongside new market entries in Canada, Hong Kong, and Europe.
Ada Torres
Ada Torres
24 Feb 2026
Perennial Investment Management has launched the Ziller Global Fund Active ETF (ASX: ZILR), targeting high-growth global companies led by exceptional founders. The fund aims to deliver absolute returns above the MSCI All Country World Index over a typical five-year horizon.
Claire Turing
Claire Turing
23 Feb 2026
Cadence Capital Limited has reported a remarkable turnaround with a 508% surge in profit after tax for the half-year ended December 2025, alongside a fully franked interim dividend declaration.
Claire Turing
Claire Turing
20 Feb 2026
Eclipse Metals reports promising Phase 1 metallurgical test results from its Grønnedal Rare Earth Element Project in Greenland, highlighting over 90% REE recovery in magnetic fractions. These findings lay the groundwork for further optimisation and scale-up testing.
Maxwell Dee
Maxwell Dee
20 Feb 2026
BPH Global is nearing completion of its novel seaweed-based men’s health supplement, Project Popeye, as it moves toward TGA listing and scientific validation.
Ada Torres
Ada Torres
19 Feb 2026
Genesis Minerals has reported a remarkable fourfold increase in net profit after tax to A$238 million for the first half of FY26, driven by a 58% rise in gold production and robust margins. The company’s strong cash position and accelerated growth plans position it well for the year ahead.
Maxwell Dee
Maxwell Dee
19 Feb 2026
Judo Capital Holdings Limited has announced a quarterly distribution of AUD 1.825 per capital note, fully franked and payable on 18 May 2026. The payment reflects a calculated yield based on prevailing market rates and remains subject to company discretion.
Victor Sage
Victor Sage
18 Feb 2026
The Environmental Group Limited reported a robust first half of FY26 with revenue rising 8.6% to $58.9 million and underlying EBITDA jumping 25.9%, driven by strong performances in its Energy and Waste divisions alongside strategic operational upgrades.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Cauldron Energy has reported a significant 32% increase in uranium resources at its Yanrey Uranium Project, highlighted by a maiden Mineral Resource Estimate for Manyingee North and an upgraded resource at Manyingee South.
Maxwell Dee
Maxwell Dee
17 Feb 2026